Home > Cardiology > AHA 2021 > Other > Concomitant tricuspid annuloplasty reduces treatment failure in moderate tricuspid regurgitation

Concomitant tricuspid annuloplasty reduces treatment failure in moderate tricuspid regurgitation

Presented By
Prof. James Gammie, University of Maryland, USA
Conference
AHA 2021
Tricuspid annuloplasty during mitral valve surgery (MVS) in patients with moderate or mild tricuspid regurgitation resulted in a decreased treatment failure compared with patients who did not receive tricuspid repair during MVS. However, an increased risk of permanent pacemaker implantation was observed in patients receiving tricuspid annuloplasty during MVS. “It is common to perform tricuspid repair during MVS in patients with mitral regurgitation and severe TR. However, there is a large variability in clinical practice regarding the threshold for performing surgery in patients with mild or moderate tricuspid regurgitation,” argued Prof. James Gammie (University of Maryland, MD, USA) [1]. Thus, the current trial investigated concomitant, undersized, rigid, non-planar tricuspid annuloplasty during MVS in patients with less than severe tricuspid regurgitation. Participants were randomised 1:1 to MVS alone (n=203) or MVS plus tricuspid annuloplasty (n=198). ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on